Processing equipment

Pall To Open Centre of Excellence in UK

08-Apr-2013

Pall has confirmed plans for a UK Centre of Excellence offering clients access to the development, testing and validation of its products.

Lack of Lava-Proof Planes Wont Stop Us Going to Interphex

08-Apr-2013 By Gareth Macdonald

So, look. Interphex is a great trade show. No doubt. 

Gore PharmBIO: New Gaskets Can Reduce Risk of Contamination

27-Mar-2013

Two new nonreactive product contact components can control contamination and meet regulatory requirements according to their makers, Gore PharmBIO.

Price of Life Tech Steady at $11B as Roche Joins Bidding War Set for April

25-Mar-2013 By Zachary Brennan

Bidders for DNA-sequencing equipment maker Life Technologies may not have to pay too much more than its current market value of $64 per share, or about $11B, according to an analyst. 

New Micron Technologies Owner Plans Investment and Acqusitions

25-Mar-2013 By Gareth Macdonald

Micron Technologies’ new private-equity owner says it plans to grow the particle engineering firm through investment and acquisitions.

Private Equity Backs Micron Technologies Management Buyout

20-Mar-2013 By Gareth Macdonald

US-based particle engineering services frim Micron Technologies has been acquired in a private-equity backed management buyout. 

EMA proposes virus testing for food sector-derived trypsin used in drugmaking

06-Mar-2013

Food industry controls do not ensure porcine trypsin is virus-free according to the EMA, which proposes testing procedures for drugmakers which use the reagent in a new consultation document.

Ajinomoto Wins ‘Top-Tier’ Pharma Licensee; Plans to Buy Althea Technologies

06-Mar-2013 By Gareth Macdonald

Ajinomoto says its flexible approach to tech licensing differs from rivals who are more focused on locking customers into manufacturing services contracts.

Collaboration With Britest Already Paying Off Says Aesica

21-Feb-2013 By Gareth Macdonald

UK CMO Aesica claims its partnership with process innovation group Britest has already increased capacity without capital investment. 

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

20-Feb-2013 By Dan Stanton

New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.

PSL says demand for HPAPI containment growing

12-Feb-2013

Powder Systems Limited (PSL) says the low OEL achieved by its redesigned containment technologies meet demands of HPAPI focused drug industry.

Flublok maker open to sharing egg and virus-free manufactuing tech

31-Jan-2013 By Gareth Macdonald

Protein Sciences says it will license the novel manufacturing technology behind recently approved influenza vaccine, Flublok, to other producers.

Freeman signs up Canadian distributor

28-Jan-2013 By Gareth Macdonald

Freeman Technologies has signed a Canadian distribution deal for its powder flow analysis tech in a bid to win more QbD and PAT-focused Pharma customers.

Asian hub’s ambition attracts Amgen into Asia biomanufacture

22-Jan-2013 By Dan Stanton

The Singapore Economic Development Board (SEDB) says it wants to nurture industry, academic and institutional alliances to attract further global investment in ‘Asia’s fastest growing bio-cluster.’

Novartis says Dendreon plant deal will drive CAR processing

10-Jan-2013 By Dan Stanton

Novartis says the acquisition of Dendreon’s Provenge plant was an investment in its activated cellular immunotherapy programme.

Bosch renames Eisai unit emphasizing inspection capabilities

09-Jan-2013 By Gareth Macdonald

Bosch has completed the integration of Japanese acquisition Eisai Machinery, renaming the unit as Bosch Inspection Technology.

Predicting most effective non-stick coatings will save Pharmas money, says I Holland

17-Dec-2012 By Gareth Macdonald

The ability to predict which non-stick coating is best suited to a particular tablet production environment will save drugmakers time and money according to I Holland.

Merck Millipore says MAb process development kit cuts experimental burden

12-Dec-2012 By Gareth Macdonald

Merck Millipore hopes the promise of reducing the number of experiments needed during process development will win customers for its new MAb development kit.

SDK invests in BIAsep to get resins know-how

10-Dec-2012

Showa Denko KK (SDK) wants a share of the of the biopharmaceutical resins sector and has partnered with purification tech firm BIA Separations (BIASep) to get it.

Sartorius Stedim Biotech launches new 'nanofleece' prefilters for bioprocessing

05-Dec-2012

Sartorius Stedim Biotech has launched a new ‘fleece-like’ prefiltration technology that it says better protects expensive downstream systems.

Brazil wants to buy Pharma tech from the Ukraine

20-Nov-2012

Brazil wants to buy pharmaceutical manufacturing technology from the Ukraine as part of a $4.5bn investment plan.

NMR culture anlaysis complies with ICH Q2A and B, says Spinnovation

20-Nov-2012

CRO Spinnovation Biologics says its cell culture optimization technique complies with analytical methods detailed in ICH Q2A and Q2B guidelines.

Micromacinazione to get bigger through Neo-Micro deal

19-Nov-2012

Micromacinazione has bought the micronization arm of Switzerland’s Neo-Micro AG, citing growth in the API sector as the key driver for the move.

Indian regulations will hike costs but market will remain competitive, Government tells IPT

15-Nov-2012 By Natalie Morrison

Domestic regulatory efforts to improve ingredient quality will increase costs but Indian industry will remain competitive, according to the Secretary of Commerce.

Evonik hikes amino acid prices in face of rising maize and sugar costs

24-Oct-2012 By Natalie Morrison

Evonik has raised the price of its pharmaceutical amino acids as a result of rising maize and sugar costs.

Disptaches from AAPS

Eliminate scale up by using R&D equipment for commercial production: GSK

18-Oct-2012 By Natalie Morrison

Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.

Merck Millipore announces 2013 price hike

18-Oct-2012

Merck Millipore has announced plans to increase what it charges for chemical and biopharmaceutical processing solutions, citing rising costs.

Dispatches from AAPS

Capsugel expands liquid fill capsule capabilities

17-Oct-2012 By Natalie Morrison

Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.

final update

SAFC invests in powder media capacity in Scotland

02-Oct-2012 By Gareth Macdonald

SAFC will add powder media manufacturing capabilities at its plant in Irvine in a move supported by the Scottish Government. 

Alchem ups sennoside production in face of pharma demand

25-Sep-2012 By Natalie Morrison & Gareth Macdonald

Alchem International has expanded its sennosides production facility in India in a bid to meet pharma demand.

Pall sets up systems 'proving ground'; signs India deal with Avacta

24-Sep-2012

Pall has opened a life science services centre to allow drugmakers to test its filtration, processing and purification technologies.

Merck Millipore introduces 'open source' development at new plant

20-Sep-2012 By Gareth Macdonald

CMOs and Pharmas will own the manufacturing processes developed at a new facility as part of an ‘open source’ ethos Merck Millipore has introduced.

GM corn could soon be used to make drugs

20-Sep-2012 By Natalie Morrison

Genetically modified corn could soon be used to mass-produce the enzymes used in rare-disease therapies, according to new research.

Tasi buys Bonfiglioli to create global leak testing tech firm

18-Sep-2012

Tasi Group has bought Bonfiglioli Engineering, creating what it claims is the largest leak testing and quality inspection technology firm in the world.

Sartorius opens new bioreactor plant to boost capacity

13-Sep-2012 By Gareth Macdonald

Sartorius has opened a new bioreactor production facility to boost capacity for single-use technologies.

Continued biopharma growth for Pall

13-Sep-2012 By Natalie Morrison

Pall Corporation has once again hailed its biopharma consumables business a key factor in its sales growth.

Takeda plans to dominate thriving Russian pharma market, starting with a new plant

11-Sep-2012 By Natalie Morrison

Takeda has opened a new $96m (€75m) pharma facility in Russia as part of its bid to “outgrow” the already thriving local market.

Genetically modified camels could produce pharma proteins in their milk

10-Sep-2012 By Natalie Morrison

Genetically modified (GM) camels could be used as a cheap way to produce the pharmaceutical proteins used in drugs – through their milk.

Merck Millipore launches new CHO media

05-Sep-2012

Merck Millipore has launched a new growth media for CHO-S cell that it claims boosts productivity and batch to batch consistency

Hospira buys Indian API plant to boost antibiotics biz

30-Aug-2012 By Natalie Morrison

Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.

UCF team accidentally discovers "game changing" nanoparticle mass production method

08-Aug-2012 By Natalie Morrison

Scientists at UCF (University of Central Florida) believe they have found a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production.

BD hunting "plug in" acquisitions

07-Aug-2012 By Natalie Morrison

BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.

People on the move: results season special

06-Aug-2012 By Natalie Morrison

Results season is well under way and in-PharmaTechnologist.com is here to bring you the latest as companies announce their chops, changes and plans for the coming quarters.

Linde says cryogenic fog can help freeze-dry biologics

31-Jul-2012 By Gareth Macdonald

Industrial gas supplier Linde claims its 'cryogenic fog' technology is the first commercially-feasible way of controlling ice-crystal formation during the lyophilisation of biologic drugs.

FDA mixed messages create QbD confusion; consultant

26-Jul-2012 By Nick Taylor

Variable understanding of QbD among US FDA reviewers is leading to mixed messages and confusion, a consultant said.

Expo Technologies rebrands as Prozess Technologie

23-Jul-2012

Expo Technologies has rebranded as Prozess Technologie and moved to a new HQ in St Louis, Missouri, US.

Lonza stresses importance of IP protection in Asia

16-Jul-2012

Lonza says the migration of major customers’ R&D operations to Asia made protecting IP for its new expression system a must.

UPDATE

‘Just add water’ for ease of cleaning HP production tech, says Bosch

05-Jul-2012 By Natalie Morrison

‘Just add water’ as a preparation for cleaning the stand-in-place tech used to produce HP compounds, says Bosh’s Johannes Rauschnabel.

Koslow launches hand-held passivation testing tech

02-Jul-2012

A new hand-held testing device can help drugmakers determine if their stainless steel tech is prone to corrosion according to developer Koslow Scientific.

A new easy way to "clean" pharma ingredients; study

28-Jun-2012 By Natalie Morrison

Scientists have uncovered a new simple way to “clean” genotoxic impurities (GTIs) in drug ingredients by mixing the solution with contamination-eating scavengers.